Recro Pharma Inc reports results for the quarter ended in September - Earnings Summary

Societal CDMO

09/11/2021 22:56

* Recro Pharma Inc  REPH.OQ  reported a quarterly adjusted loss
of 7 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 7 cents per share.
* Revenue fell 5.4% to $18.24 million from a year ago;  analysts
expected $18.07 million. 
* Recro Pharma Inc's reported EPS for the quarter was a loss
of 7 cents​.
* The mean earnings estimate of analysts had fallen by
about 22.2% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Recro Pharma Inc shares had fallen by 7.8% this quarter and
lost 33.3% so far this year.
* The company reported a quarterly loss of $3.49 million.
* Wall Street's median 12-month price target for Recro Pharma
Inc is $5.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 10:56 p.m.
 ​All figures in US dollars unless otherwise stated